Interv Akut Kardiol. 2014;13(1):23-26

Troponins in diagnostics of acute coronary syndromes - update 2014

Radek Pudil
1. interní kardioangiologická klinika LF UK a FN Hradec Králové

The introduction of highly-sensitive method for the assessment of cardiac troponins represents a progress in diagnostics, therapy and

risk stratification in acute coronary syndromes. It provides earlier diagnosis and increase of the sensitivity in the diagnostic process of

acute myocardial infarction. Further increase of the sensitivity can be achieved with simultaneous assessment of other markers (copeptin,

heart fatty acid binding protein) or evaluation of additional clinical parameters (electrocardiogram, GRACE or TIMI risk score). The

question of the rule-out protocols remains opened in the process of evaluation of the coronary etiology of chest pain.

Keywords: acute coronary syndromes, high-sensitive troponin, rule-in, rule-out protocols

Published: March 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Pudil R. Troponins in diagnostics of acute coronary syndromes - update 2014. Interv Akut Kardiol. 2014;13(1):23-26.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-969. Go to original source... Go to PubMed...
    2. International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on the Standardization of Markers of cardiac Damage (C-SMCD), Troponin assay analytical characteristics. Available at: http://www.ifcc.org/media/102199/IFCC_Troponin_Table_vDec_2010_FINAL_ng_L_28Jan11.pdf, 2003 (accessed June 11, 2011).
    3. Mueller C. Biomarkers and acute coronary syndromes: an update Eur Heart J. doi: 10.1093/eurheartj/eht530).(Vasatova M, Pudil R, Horacek JM, Buchler T. Current applications of cardiac troponin T for the diagnosis of myocardial damage. Adv Clin Chem 2013; 61: 33-65.
    4. La'ulu SL, Roberts WL. Performance characteristics of five cardiac troponin I assays. Clin Chim Acta 2010; 411: 1095-1101. Go to original source... Go to PubMed...
    5. Daubert MA, Jeremias A. The utility of troponin measurement to detect myocardial infarction: review of the current findings. Vasc Health Risk Manag 2010; 6: 691-699. Go to original source... Go to PubMed...
    6. Thygesen K, Mair J, Giannitsis E, et al. How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J 2012; 33(18): 2252-2257. Go to original source... Go to PubMed...
    7. Twerenbold R, Jaffe A, Reichlin T, Reiter M, Mueller C. High-sensitive troponin T measurements: what do we gain and what are the challenges? Eur Heart J 2012; 33: 579-586. Go to original source... Go to PubMed...
    8. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33(20): 2551-2567. Go to original source... Go to PubMed...
    9. White HD. Pathobiology of troponin elevations: do elevations occur with myocardial ischemia as well as necrosis? J Am Coll Cardiol 2011; 57(24): 2406-2408. Go to original source... Go to PubMed...
    10. Hoeller R, Giménez MR, Reichlin T, et al. Normal presenting levels of high sensitivity troponin and myocardial infacrtion. Heart 2013; 99: 1567-1572 doi: 10.1136/heartjnl-2013-303643. Go to original source... Go to PubMed...
    11. Steg PG, James SK, Atar D, et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012; 33: 2569-2619. Go to original source... Go to PubMed...
    12. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011; 32(23): 2999-3054. Go to original source... Go to PubMed...
    13. Janota T. Biochemické markery nekrózy myokardu v současné klinické praxi. Interv Akut Kardiol 2013; 12(1): 28-33.
    14. Fox KA, Carruthers K, Dunbar DR, et al. Underestimated and underrecognized: the late consequences of acute coronary syndrome (GRACE UK - Belgian Study). Eur Heart J 2010; 31:2755-2764. Go to original source... Go to PubMed...
    15. Biener M, Mueller M, Vafaie M, et al. Comparison of a 3-hour versus a 6-hour sampling-protocol using high-sensitivity cardiac troponin T for rule-out and rule-in of non-STEMI in an unselected emergency department population. Int J Cardiol 2013; 167(4): 1134-1140. Go to original source... Go to PubMed...
    16. Giannitsis E, Becker M, Kurz K, et al. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010; 56: 642-650. Go to original source... Go to PubMed...
    17. Reichlin T, Irfan A, Twerenbold R, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 2011; 124(2): 136-145. Go to original source... Go to PubMed...
    18. Body R, Carley S, McDowell G, et al. Rapid exclusion of acute myocardial infarction in patients with undetectable troponin using a high-sensitivity essay. J Am Coll Cardiol 2011; 58: 1332-1339. Go to original source... Go to PubMed...
    19. Mueller M, Biener M, Vafaie M, et al. Absolute and relative kinetic changes of highsensitivity cardiac troponin T in acute coronary syndrome and in patients with increased troponin in the absence of acute coronary syndrome. Clin Chem 2012; 58: 209-218.. Go to original source... Go to PubMed...
    20. Aldous SJ, Florkowski CM, Crozier IG, et al. Comparison of high sensitivity and contemporary troponin assays for the early detection of acute myocardial infarction in the emergency department. Ann Clin Biochem 2011; 48: 241-248. Go to original source... Go to PubMed...
    21. Raskovalova T, Twerenbold R, Collinson PO, et al. Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis. DOI: 10.1177/2048872613514015.
    22. Than M, Cullen L, Aldous S, et al. 2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain Symptoms Using Contemporary Troponins as the Only Biomarker: The ADAPT Trial. J. Am. Coll. Cardiol. 2012; 59: 2091-2098. Go to original source... Go to PubMed...
    23. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010; 56(2): 254-261. Go to original source... Go to PubMed...
    24. Cardiology Today. High-STEACS: Troponin test could improve accuracy of MI diagnosis in women. http://www.healio.com/cardiology/vascular-medicine/news/online/%7B557eb81f-463a-4372-8df3-b6bfea47098d%7D/high-steacs-troponin-test-could-improve-accuracy-of-mi-diagnosis-in-women).
    25. Cardinaels E, Mingels A, Jacobs L. A comprehensive review of upper reference limits reported for (high-) sensitivity cardiac troponin assays: the challenges that lie ahead, Clin Chem Lab Med 2012; 50: 791-806. Go to original source... Go to PubMed...
    26. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012; 58: 54 - 61. Go to original source... Go to PubMed...
    27. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59: 607-609.

    Return to the content


    Interventional Cardiology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.